DRKS00040790进行中（未招募）不适用
A Comparative Qualitative Interview Study of Self-Care Among Partners of Individuals with Cancer and Partners of Individuals with Frontotemporal Dementia (FTD)
Universitätsklinikum Ulm, Klinik für Psychosomatische Medizin und Psychotherapie0 个研究点目标入组 30 人开始时间: 2026年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- •Age of majority, sufficient German language skills, informed consent, partners of cancer patients (initial diagnosis or relapse) or partners of FTD patients.
排除标准
- •Partner with a history of cancer or FTD
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-controlled Study to Evaluate AMG 162 in theTreatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy forNon-metastatic Prostate CancerEUCTR2004-000512-17-HUAmgen Inc968
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-controlled Study to Evaluate AMG 162 in theTreatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy forNon-metastatic Prostate CancerBone loss in pateints undergoing androgen-deprivation therapy (ADT) for non-metastatic prostate cancer.MedDRA version: 8.1Level: LLTClassification code 10049470Term: Bone density decreasedEUCTR2004-000512-17-CZAmgen Inc1,468
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-controlled Study to Evaluate AMG 162 in theTreatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy forNon-metastatic Prostate CancerBone loss in pateints undergoing androgen-deprivation therapy (ADT) for non-metastatic prostate cancer.MedDRA version: 8.1Level: LLTClassification code 10049470Term: Bone density decreasedEUCTR2004-000512-17-FIAmgen Inc1,468
进行中（未招募）
不适用
Randomized, Double-Blind, Placebo-Controlled Trial of etanercept plus methotrexate in monoclonal antibody (mAb) anti-TNF failureMedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid ArthritisEUCTR2012-003644-71-ESPfizer Inc.168
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Heterozygous Familial HypercholesterolemiaHypercholesterolaemiaMedDRA version: 20.0Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2017-001903-60-ESSanofi-aventis recherche & développement153